Skip to main content
Top
Published in: International Journal of Hematology 5/2022

01-05-2022 | Lymphoma | Images in Hematology

Clostridium septicum myonecrosis following chemotherapy

Authors: Omali Pitiyarachchi, Nicholas Viiala

Published in: International Journal of Hematology | Issue 5/2022

Login to get access

Excerpt

A 45-year-old non-diabetic woman receiving hyper-CVAD (hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone) chemotherapy for suspected high-grade transformation of follicular lymphoma presented to the emergency department with febrile neutropenia and left flank pain radiating down the left leg that was not responsive to high-dose morphine. Laboratory findings were profound neutropenia (neutrophil count 0.0 × 109/L), thrombocytopenia (platelet count 17 × 109/L), and elevated CRP (13.22 mg/dL). Computed tomography of the abdomen and pelvis showed extensive abnormal gas around the left ilium causing its destruction, with necrosis of adjacent gluteal muscles, and gas extending into the left sacrum, pubic ramus and right inferior epigastric vein (Fig. 1). The patient deteriorated rapidly with septic shock and died 10 h later despite broad-spectrum intravenous antibiotics and inotropic support in the intensive care unit. Blood cultures later grew Clostridium septicum, as well as Staphylococcus aureus and Gram-variable bacilli.
Literature
1.
go back to reference Srivastava I, Aldape MJ, Bryant AE, Stevens DL. Spontaneous C. septicum gas gangrene: a literature review. Anaerobe. 2017;48:165–71.CrossRef Srivastava I, Aldape MJ, Bryant AE, Stevens DL. Spontaneous C. septicum gas gangrene: a literature review. Anaerobe. 2017;48:165–71.CrossRef
Metadata
Title
Clostridium septicum myonecrosis following chemotherapy
Authors
Omali Pitiyarachchi
Nicholas Viiala
Publication date
01-05-2022
Publisher
Springer Nature Singapore
Published in
International Journal of Hematology / Issue 5/2022
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-022-03326-8

Other articles of this Issue 5/2022

International Journal of Hematology 5/2022 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine